Skip to main content
  • MIPS 2022—Small or Large Practice?

    This content is excerpted from EyeNet’s MIPS 2022: A Primer and Reference; also see the Academy’s MIPS hub page.

    Practice size is determined by CMS based on the number of eligible clinicians in a practice:

    • Small practices have 15 or fewer eligible clinicians.
    • Large practices have 16 or more eligible clinicians.

    CMS uses claims data to assign practice size. CMS determines how many eligible clinicians are in a practice by reviewing claims data during two 12-month time periods (see “MIPS Determination Period”) and looking at the number of National Provider Identifiers (NPIs) associated with the practice’s Taxpayer Identification Number (TIN). This would include NPIs of eligible clinicians who are not MIPS eligible clinicians—see “Who Does (and Doesn’t) Take Part in MIPS.”

    Why practice size matters. CMS provides small practices with accommodations that can help them to boost their MIPS final score. For example, CMS doubles their score for performing improvement activities, adds a 6-point bonus to their quality score, gives them a 3-point floor on quality measures, and only small practices can report quality measures via Medicare Part B claims, as described in the Academy Claims Reporting Guide. New for 2022: Small practices will automatically be excluded from the promoting interoperability (PI) performance category unless they report on PI measures.

    Is your practice small or large? CMS will post its practice size determinations online (see “What’s Your MIPS Participation Status”).

    Previous: Low-Volume Clinicians Can Opt In to MIPS

    Next: Use of TINs and NPIs as Identifiers 

    DISCLAIMER AND LIMITATION OF LIABILITY: Meeting regulatory requirements is a complicated process involving continually changing rules and the application of judgment to factual situations. The Academy does not guarantee or warrant that regulators and public or private payers will agree with the Academy’s information or recommendations. The Academy shall not be liable to you or any other party to any extent whatsoever for errors in, or omissions from, any such information provided by the Academy, its employees, agents, or representatives.

    COPYRIGHT© 2022, American Academy of Ophthalmology, Inc.® All rights reserved. No part of this publication may be reproduced without written permission from the publisher. American Academy of Ophthalmic Executives® and IRIS® Registry, among other marks, are trademarks of the American Academy of Ophthalmology®.

    All of the American Academy of Ophthalmology (AAO)–developed quality measures are copyrighted by the AAO’s H. Dunbar Hoskins Jr., MD, Center for Quality Eye Care (see terms of use).